Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
0.7412
-0.0187 (-2.46%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Opus Genetics Stock Forecast
IRD's stock price has decreased by -55.21% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Opus Genetics stock have an average target of 7.00, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 844.41% from the current stock price of 0.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Opus Genetics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +709.50% | Apr 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +979.33% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +979.33% | Feb 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +979.33% | Dec 12, 2024 |
Financial Forecast
Revenue This Year
15.07M
from 10.99M
Increased by 37.05%
Revenue Next Year
25.26M
from 15.07M
Increased by 67.67%
EPS This Year
-1.00
from -2.15
EPS Next Year
-0.39
from -1.00
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 18.2M | 29.3M | 41.3M |
| Avg | 15.1M | 25.3M | 31.6M |
| Low | 12.3M | 21.7M | 22.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 65.3% | 94.5% | 63.3% |
| Avg | 37.1% | 67.7% | 25.1% |
| Low | 11.7% | 43.9% | -9.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.00 | -0.21 | 0.82 |
| Avg | -1.00 | -0.39 | 0.13 |
| Low | -1.01 | -0.74 | -0.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.